The Role of Aldosterone in Detecting Resistance-Driven Hypoaldosteronism and Deficit-Driven Hypoaldosteronism
<b>Background/Objectives</b>: Hypoaldosteronism is classified into "aldosterone deficit" (Aldo-D) and "aldosterone/mineralocorticoid resistance" (Aldo-R) based on etiopathogenic mechanisms. This distinction could be useful for guiding the treatment. However, no reliable methods have been established to differentiate these subtypes. We first aimed to assess whether aldosterone levels could help identify them when assessed in the setting of hyperkalemia or hyperreninemia. <b>Methods</b>: We conducted a retrospective analysis of eighty-four cases of hypoaldosteronism. Aldo-D and Aldo-R classification was based on the presence of clinical factors associated with aldosterone deficit and mineralocorticoid resistance, respectively. The accuracy of plasma aldosterone (PAC) to identify each type of hypoaldosteronism individually was evaluated using AUC-ROC analysis. <b>Results</b>: Aldo-D was identified in 66 (78.6%), and Aldo-R in 41 (48.8%) cases. Factors related to both subtypes were observed in forty-seven (56%) cases. AUC-ROC analysis of PAC measured during hyperkalemia showed low accuracy for detecting either subtype. During hyperreninemia, PAC accuracy was adequate for identifying Aldo-D but unsatisfactory for Aldo-R. Nevertheless, a PAC ≤ 60 pg/mL (6 ng/dL, ~166 pmol/L) during hyperkalemia and hyperreninemia yielded positive predictive values (PPV) of 94% and 100%, respectively, for Aldo-D, while a PAC value > 160 pg/mL (~443 pmol/L), particularly ≥ 200 pg/mL (20 ng/dL, ~550 pmol/L) in either condition had a PPV of 100% for Aldo-R. <b>Conclusions</b>: Although overall diagnostic accuracy was limited, extreme low and high PAC values (≤ 60 pg/mL or ≥ 200 pg/mL) may be suggestive of Aldo-D or Aldo-R, respectively, while intermediate values remain difficult to interpret due to substantial overlap.
Authors
- Alfonso L. Calle‐Pascual (ORCID: https://orcid.org/0000-0002-3628-9323)
- Isabelle Rünkle (ORCID: https://orcid.org/0000-0001-5605-8525)
- Emilia Gómez Hoyos (ORCID: https://orcid.org/0000-0001-7079-6356)
- Paz De Miguel Novoa
- Miguel Ángel Rubio-Herrera
- Jorge Gabriel Ruiz-Sánchez
Institutions
- Universidad Complutense de Madrid (ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Hospital Clínico Universitario de Valladolid (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-12-27
- DOI
- https://doi.org/10.3390/jcm15010218
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Comunidad de Madrid
- Sociedad de Endocrinología, Nutrición y Diabetes de la Comunidad de Madrid